Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid

		Cancer Friends Network > Types of Cancer > Leukemia
Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-27-2012, 08:38 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid

Celator Pharmaceuticals today announced that the European Commission has granted orphan drug status to CPX-351, the company’s proprietary “liposomal combination of cytarabine and daunorubicin,” for the treatment of acute myeloid leukemia .

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 03:28 PM.

CancerFriends.net